Cardiol Therapeutics (CRDL) Short Interest Ratio & Short Volume $1.08 +0.01 (+0.93%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$1.10 +0.01 (+1.39%) As of 06:31 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cardiol Therapeutics Short Interest DataCardiol Therapeutics (CRDL) has a short interest of 1.72 million shares, representing 2.19% of the float (the number of shares available for trading by the public). This marks a -7.53% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.8, indicating that it would take 7.8 days of the average trading volume of 676,965 shares to cover all short positions.Current Short Interest1,720,000 sharesPrevious Short Interest1,860,000 sharesChange Vs. Previous Month-7.53%Dollar Volume Sold Short$2.22 millionShort Interest Ratio7.8 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares82,675,000 sharesFloat Size78,700,000 sharesShort Percent of Float2.19%Today's Trading Volume1,211,249 sharesAverage Trading Volume676,965 sharesToday's Volume Vs. Average179% Short Selling Cardiol Therapeutics? Sign up to receive the latest short interest report for Cardiol Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCRDL Short Interest Over TimeCRDL Days to Cover Over TimeCRDL Percentage of Float Shorted Over Time Cardiol Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20251,720,000 shares $2.22 million -7.5%2.2%7.8 $1.29 6/30/20251,860,000 shares $2.53 million -2.6%2.4%9.5 $1.36 6/15/20251,910,000 shares $2.79 million -4.0%2.4%9.4 $1.46 5/31/20251,990,000 shares $2.48 million +8.2%2.5%9.7 $1.25 5/15/20251,840,000 shares $2.10 million -8.9%2.3%9.4 $1.14 4/30/20252,020,000 shares $2.22 million -1.0%2.6%9.1 $1.10 4/15/20252,040,000 shares $2.16 million +10.3%2.6%8.7 $1.06 3/31/20251,850,000 shares $1.79 million +5.1%2.4%7.3 $0.97 3/15/20251,760,000 shares $1.99 million -5.9%2.3%6.5 $1.13 2/28/20251,870,000 shares $2.15 million +26.4%2.4%6.2 $1.15 Get the Latest News and Ratings for CRDL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20251,480,000 shares $1.81 million +3.5%1.9%4.5 $1.22 1/31/20251,430,000 shares $2.02 million -8.3%1.8%4 $1.41 1/15/20251,560,000 shares $1.92 million +18.2%2.0%4.3 $1.23 12/31/20241,320,000 shares $1.69 million +3.9%1.7%2.7 $1.28 12/15/20241,270,000 shares $1.69 million +12.4%1.6%2.6 $1.33 11/30/20241,130,000 shares $1.83 million +26.5%1.5%2.3 $1.62 11/15/2024893,300 shares $1.63 million +9.6%1.2%1.9 $1.82 10/31/2024814,800 shares $1.47 million -17.8%1.2%1.9 $1.80 10/15/2024991,600 shares $1.89 million +39.6%1.5%2.4 $1.91 9/30/2024710,500 shares $1.41 million -1.1%1.1%1.8 $1.98 9/15/2024718,400 shares $1.78 million -0.9%1.1%2.3 $2.48 8/31/2024724,600 shares $1.41 million -3.7%1.1%1.7 $1.94 8/15/2024752,500 shares $1.54 million -4.3%1.1%1.6 $2.04 7/31/2024786,600 shares $1.70 million +2.5%1.2%1.6 $2.16 7/15/2024767,700 shares $1.64 million -13.6%1.2%1.5 $2.13 6/30/2024888,500 shares $1.79 million +14.5%1.4%1.8 $2.02 6/15/2024776,300 shares $1.87 million +107.6%1.2%1.5 $2.41 5/31/2024374,000 shares $979.88 thousand +40.3%0.6%1 $2.62 5/15/2024266,500 shares $618.28 thousand -18.8%0.4%0.8 $2.32 4/30/2024328,100 shares $659.48 thousand +19.2%0.5%0.8 $2.01 4/15/2024275,200 shares $492.61 thousand -15.7%0.4%0.7 $1.79 3/31/2024326,600 shares $591.15 thousand +19.6%0.5%0.8 $1.81 3/15/2024273,000 shares $414.96 thousand -24.4%0.4%0.8 $1.52 2/29/2024361,100 shares $743.87 thousand +108.1%0.6%1.1 $2.06 2/15/2024173,500 shares $256.78 thousand +16.6%0.3%0.6 $1.48 1/31/2024148,800 shares $181.54 thousand +24.4%0.2%0.9 $1.22 1/15/2024119,600 shares $124.38 thousand -9.1%0.2%0.8 $1.04 12/31/2023131,500 shares $110.88 thousand -31.4%0.2%0.7 $0.84 12/15/2023191,800 shares $165.93 thousand -14.7%0.3%0.9 $0.87 11/30/2023224,800 shares $206.03 thousand -11.9%0.4%1 $0.92HIDDEN IN THE BOOK OF GENESIS… (Ad)“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.Watch Jim Rickards reveal the Old Testament Wealth Code 11/15/2023255,200 shares $214.37 thousand -17.5%0.4%1.2 $0.84 10/31/2023309,500 shares $256.89 thousand -4.8%0.5%1.4 $0.83 10/15/2023325,100 shares $266.58 thousand +32.1%0.5%1.2 $0.82 9/30/2023246,100 shares $220.26 thousand +132.0%0.4%1.2 $0.90 9/15/2023106,100 shares $103.45 thousand +46.6%0.2%0.6 $0.98 8/31/202372,400 shares $79.64 thousand -49.2%0.1%0.4 $1.10 8/15/2023142,400 shares $134.48 thousand +8.5%0.2%0.8 $0.94 7/31/2023131,200 shares $141.70 thousand +49.3%0.2%0.7 $1.08 7/15/202387,900 shares $71.54 thousand +3.8%0.1%0.7 $0.81 6/30/202384,700 shares $75.38 thousand -26.7%0.1%0.6 $0.89 6/15/2023115,500 shares $91.53 thousand -23.8%0.2%0.8 $0.79 5/31/2023151,500 shares $102.13 thousand +1.3%0.3%1.3 $0.67 5/15/2023149,600 shares $82.28 thousand +18.8%0.2%1.5 $0.55 4/30/2023125,900 shares $78.01 thousand -21.1%0.2%1.1 $0.62 4/15/2023159,500 shares $82.54 thousand -12.9%0.3%1.5 $0.52 3/31/2023183,100 shares $89.22 thousand +8.9%0.3%1.8 $0.49 3/15/2023168,100 shares $82.37 thousand +8.3%0.3%1.7 $0.49 2/28/2023155,200 shares $82.32 thousand -41.3%0.3%1.3 $0.53 2/15/2023264,500 shares $150.77 thousand -10.0%0.5%2.2 $0.57 1/31/2023293,800 shares $206.92 thousand +8.9%0.5%2.3 $0.70 1/15/2023269,800 shares $217.35 thousand +6.7%0.5%1.9 $0.81 12/30/2022252,900 shares $128.98 thousand +11.0%0.4%1.5 $0.51 12/15/2022227,800 shares $152.63 thousand -3.1%0.4%1.1 $0.67 11/30/2022235,100 shares $121.15 thousand +10.3%0.4%1 $0.52 11/15/2022213,100 shares $135.17 thousand -10.8%0.4%0.8 $0.63 10/31/2022239,000 shares $143.11 thousand -33.0%0.4%0.9 $0.60 10/15/2022356,900 shares $232.70 thousand -29.6%0.6%1.4 $0.65 9/30/2022506,600 shares $521.80 thousand +2.2%0.9%2.2 $1.03 9/15/2022495,800 shares $609.83 thousand +3.1%0.9%2.6 $1.23 8/31/2022481,100 shares $538.83 thousand +22.4%0.8%3.1 $1.12 8/15/2022393,200 shares $499.36 thousand +9.2%0.7%2.8 $1.27 7/31/2022360,200 shares $475.46 thousand -9.4%0.6%2.5 $1.32 7/15/2022397,700 shares $505.08 thousand -17.5%0.7%2.2 $1.27 6/30/2022482,300 shares $636.64 thousand -13.1%0.8%1.8 $1.32 6/15/2022554,700 shares $787.67 thousand +44.8%1.0%1.9 $1.42 5/31/2022383,100 shares $513.35 thousand -13.4%0.7%1.3 $1.34 5/15/2022442,400 shares $522.03 thousand -14.1%0.8%1.5 $1.18 4/30/2022514,700 shares $705.14 thousand -2.8%0.9%1.7 $1.37 4/15/2022529,600 shares $1.09 million +65.7%0.9%1.7 $2.05 3/31/2022319,600 shares $488.99 thousand -20.5%0.6%1 $1.53 3/15/2022401,900 shares $566.68 thousand +4.6%0.7%1.2 $1.41 2/28/2022384,100 shares $645.29 thousand -11.0%0.7%1 $1.68 2/15/2022431,500 shares $781.02 thousand +13.3%0.8%1.1 $1.81 1/31/2022381,000 shares $704.85 thousand +119.3%0.7%0.7 $1.85 1/15/2022173,700 shares $347.40 thousand -27.2%0.7%0.2 $2.00 12/31/2021238,600 shares $441.41 thousand No Change1.0%0.3 $1.85 CRDL Short Interest - Frequently Asked Questions What is Cardiol Therapeutics' current short interest? Short interest is the volume of Cardiol Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 1,720,000 shares of CRDL short. 2.19% of Cardiol Therapeutics' shares are currently sold short. Learn More on Cardiol Therapeutics' current short interest. What is a good short interest ratio for Cardiol Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRDL shares currently have a short interest ratio of 8.0. Learn More on Cardiol Therapeutics's short interest ratio. What is a good short interest percentage for Cardiol Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.19% of Cardiol Therapeutics' floating shares are currently sold short. Is Cardiol Therapeutics' short interest increasing or decreasing? Cardiol Therapeutics saw a decline in short interest in July. As of July 15th, there was short interest totaling 1,720,000 shares, a decline of 7.5% from the previous total of 1,860,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cardiol Therapeutics' float size? Cardiol Therapeutics currently has issued a total of 82,675,000 shares. Some of Cardiol Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cardiol Therapeutics currently has a public float of 78,700,000 shares. How does Cardiol Therapeutics' short interest compare to its competitors? 2.19% of Cardiol Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cardiol Therapeutics: Kodiak Sciences Inc. (5.12%), Precigen, Inc. (19.44%), PureTech Health PLC Sponsored ADR (0.02%), REGENXBIO Inc. (12.32%), Savara Inc. (25.67%), Kamada Ltd. (0.30%), Compass Therapeutics, Inc. (8.91%), Fulcrum Therapeutics, Inc. (9.10%), Gossamer Bio, Inc. (7.97%), Tectonic Therapeutic, Inc. (18.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Cardiol Therapeutics stock? Short selling CRDL is an investing strategy that aims to generate trading profit from Cardiol Therapeutics as its price is falling. CRDL shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cardiol Therapeutics? A short squeeze for Cardiol Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CRDL, which in turn drives the price of the stock up even further. How often is Cardiol Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRDL, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies Kodiak Sciences Short Interest Precigen Short Interest PureTech Health Short Interest REGENXBIO Short Interest Savara Short Interest Kamada Short Interest Compass Therapeutics Short Interest Fulcrum Therapeutics Short Interest Gossamer Bio Short Interest Tectonic Therapeutic Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CRDL) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
